Becker’s Hospital Review
Buyer Beware: DOJ Pursuing Private Equity Investors in Healthcare
December 20, 2018
As many in the healthcare industry have come to appreciate, the Civil War-era False Claims Act (“FCA”) is an exceptionally broad statute that has been the Department of Justice’s (“DOJ”) primary lever over the last twenty years in extracting billions of dollars of recoveries from healthcare providers accused of conduct ranging from clear fraud to regulatory infractions.
View the complete article on the Becker's Hospital Review website.
Contacts
Related Blogs
Capabilities
Suggested News & Insights
Fourth Circuit Highlights Tougher Path to Dismissal of FCA Cases Post-SuperValuMarch 18, 2026Fifth Circuit Panel Produces Three Opinions Wrestling with Application of First to File BarMarch 13, 2026Sidley Wins a Trio of Awards at the 2026 Benchmark Litigation US AwardsMarch 12, 2026Sidley Advises Verdane in Its Partnership With SmartboxMarch 12, 2026New U.S. DOJ Antitrust Leadership Signals More Criminal Prosecutions and Longer Prison SentencesMarch 6, 2026Strictly Enforcing Rule 9(b), Second Circuit Affirms Dismissal of FCA Claim Based on Allegedly Defective Medical DevicesMarch 4, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
